A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
Clinical trial NCT01314664 · TERMINATED
Trial details
- NCT number
- NCT01314664
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.